Diagnostic testing in suspected fluoroquinolone hypersensitivity

Clinical and Experimental Allergy

Volumn 39, Issue 11, 2009, Pages 1738-1745

  Seitz, C S ^a,b   Brocker E B ^a   Trautmann, A ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Anaphylaxis; Challenge test; Exanthema; Provocation test; Skin test; Urticaria

Indexed keywords

CIPROFLOXACIN; IMMUNOGLOBULIN E; LEVOFLOXACIN; MOXIFLOXACIN; OFLOXACIN;

ABDOMINAL PAIN; ADULT; AGED; ANAPHYLAXIS; ANGIONEUROTIC EDEMA; ARTICLE; BASOPHIL; BRONCHOSPASM; CELL ACTIVATION; CLINICAL EVALUATION; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; DISEASE SEVERITY; DRUG DOSE INCREASE; DRUG ERUPTION; DRUG HYPERSENSITIVITY; DYSPNEA; FEMALE; HUMAN; HYPOTENSION; IMMEDIATE TYPE HYPERSENSITIVITY; INCONTINENCE; MAJOR CLINICAL STUDY; MALE; PRICK TEST; PRIORITY JOURNAL; RASH; RESPIRATORY TRACT INFECTION; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SKIN INFECTION; SKIN TEST; SOFT TISSUE INFECTION; TACHYCARDIA; URINARY TRACT INFECTION; URTICARIA; VOMITING;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANAPHYLAXIS; ANTI-BACTERIAL AGENTS; DRUG HYPERSENSITIVITY; FEMALE; FLUOROQUINOLONES; HUMANS; HYPERSENSITIVITY, DELAYED; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SKIN TESTS;

EID: 70350289672     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2009.03338.x     Document Type: Article

References (37)

1. Oliphant CM, Green GM. Quinolones: a comprehensive review. Am Fam Physician 2002 65 : 455 464.
2. Mehlhorn AJ, Brown DA. Safety concerns with fluoroquinolones. Ann Pharmacother 2007 41 : 1859 1866.
3. Leone R, Venegoni M, Motola D et al. Adverse drug reactions related to the use of fluoroquinolone antimicrobials: an analysis of spontaneous reports and fluoroquinolone consumption data from three Italian regions. Drug Saf 2003 26 : 109 120.
4. Sachs B, Riegel S, Seebeck J et al. Fluoroquinolone-associated anaphylaxis in spontaneous adverse drug reaction reports in Germany: differences in reporting rates between individual fluoroquinolones and occurrence after first-ever use. Drug Saf 2006 29 : 1087 1100.
5. Campi P, Pichler WJ. Quinolone hypersensitivity. Curr Opin Allergy Clin Immunol 2003 3 : 275 281.
6. Manfredi M, Severino M, Testi S et al. Detection of specific IgE to quinolones. J Allergy Clin Immunol 2004 113 : 155 160.
7. Rodriguez-Morales A, Llamazares AA, Benito RP, Cocera CM. Fixed drug eruption from quinolones with a positive lesional patch test to ciprofloxacin. Contact Dermat 2001 44 : 255.
8. Jongen-Lavrencic M, Schneeberger PM, van der Hoeven JG. Ciprofloxacin-induced toxic epidermal necrolysis in a patient with systemic lupus erythematosus. Infection 2003 31 : 428 429.
9. Schmid DA, Depta JP, Pichler WJ. T cell-mediated hypersensitivity to quinolones: mechanisms and cross-reactivity. Clin Exp Allergy 2006 36 : 59 69.
10. Executive summary of disease management of drug hypersensitivity: a practice parameter. Joint Task Force on Practice Parameters. The American Academy of Allergy, Asthma and Immunology. The American Academy of Allergy, Asthma and Immunology. The Joint Council of Allergy, Asthma and Immunology. Ann Allergy Asthma Immunol 1999 83 : 665 700.
11. Scherer K, Bircher AJ. Hypersensitivity reactions to fluoroquinolones. Curr Allergy Asthma Rep 2005 5 : 15 21.
12. Aberer W, Bircher A, Romano A et al. Drug provocation testing in the diagnosis of drug hypersensitivity reactions: general considerations. Allergy 2003 58 : 854 863.
13. Brown SG. Clinical features and severity grading of anaphylaxis. J Allergy Clin Immunol 2004 114 : 371 376.
14. Brockow K, Romano A, Blanca M, Ring J, Pichler W, Demoly P. General considerations for skin test procedures in the diagnosis of drug hypersensitivity. Allergy 2002 57 : 45 51.
15. Schwartz LB, Bradford TR, Rouse C et al. Development of a new, more sensitive immunoassay for human tryptase: use in systemic anaphylaxis. J Clin Immunol 1994 14 : 190 204.
16. Boumiza R, Debard AL, Monneret G. The basophil activation test by flow cytometry: recent developments in clinical studies, standardization and emerging perspectives. Clin Mol Allergy 2005 3 : 9 16.
17. Trcka J, Schmidt C, Seitz CS, Bröcker EB, Gross GE, Trautmann A. Anaphylaxis to iodinated contrast materia: nonallergic hypersensitivity or IgE-mediated allergy? Am J Roentgenol 2008 190 : 666 670.
18. Ebo DG, Bridts CH, Hagendorens MM, Mertens CH, De Clerck LS, Stevens WJ. Flow-assisted diagnostic management of anaphylaxis from rocuronium bromide. Allergy 2006 61 : 935 939.
19. Trcka J, Seitz CS, Bröcker EB, Gross GE, Trautmann A. Aminopenicillin-induced exanthema allows treatment with certain cephalosporins or phenoxymethyl penicillin. J Antimicrob Chemother 2007 60 : 107 111.
20. The diagnosis and management of anaphylaxis: an updated practice parameter. J Allergy Clin Immunol 2005 115 : 483 523.
21. Schmid DA, Campi P, Pichler WJ. Hypersensitivity reactions to quinolones. Curr Pharm Des 2006 12 : 3313 3326.
22. Barbaud A, Trechot P, Reichert-Penetrat S, Commun N, Schmutz JL. Relevance of skin tests with drugs in investigating cutaneous adverse drug reactions. Contact Dermat 2001 45 : 265 268. (Pubitemid 33032964)
23. Empedrad R, Darter AL, Earl HS, Gruchalla RS. Nonirritating intradermal skin test concentrations for commonly prescribed antibiotics. J Allergy Clin Immunol 2003 112 : 629 630.
24. Erdem G, Staat MA, Connelly BL, Assaad A. Anaphylactic reaction to ciprofloxacin in a toddler: successful desensitization. Pediatr Infect Dis J 1999 18 : 563 564.
25. Ronnau AC, Sachs B, von Schmiedeberg S et al. Cutaneous adverse reaction to ciprofloxacin: demonstration of specific lymphocyte proliferation and cross-reactivity to ofloxacin in vitro. Acta Derm Venereol 1997 77 : 285 288.
26. Lode H, Hoffken G, Boeckk M, Deppermann N, Borner K, Koeppe P. Quinolone pharmacokinetics and metabolism. J Antimicrob Chemother 1990 26 : 41 9.
27. Pichler WJ, Tilch J. The lymphocyte transformation test in the diagnosis of drug hypersensitivity. Allergy 2004 59 : 809 820.
28. Mirakian R, Ewan PW, Durham SR et al. BSACI guidelines for the management of drug allergy. Clin Exp Allergy 2009 39 : 43 61.
29. Gruchalla RS, Pirmohamed M. Clinical practice. Antibiotic allergy. N Engl J Med 2006 354 : 601 609.
30. Solensky R, Earl HS, Gruchalla RS. Lack of penicillin resensitization in patients with a history of penicillin allergy after receiving repeated penicillin courses. Arch Intern Med 2002 162 : 822 826.
31. Lantner RR. Ciprofloxacin desensitization in a patient with cystic fibrosis. J Allergy Clin Immunol 1995 96 : 1001 1002.
32. Gea-Banacloche JC, Metcalfe DD. Ciprofloxacin desensitization. J Allergy Clin Immunol 1996 97 : 1426 1427.
33. Davis H, McGoodwin E, Reed TG. Anaphylactoid reactions reported after treatment with ciprofloxacin. Ann Intern Med 1989 111 : 1041 1043.
34. Kurata M, Kasuga Y, Nanba E, Nakamura H, Asano T, Haruta K. Flush induced by fluoroquinolones in canine skin. Inflamm Res 1995 44 : 461 465.
35. Alonso MD, Martin JA, Quirce S, Davila I, Lezaun A, Sanchez CM. Fixed eruption caused by ciprofloxacin with cross-sensitivity to norfloxacin. Allergy 1993 48 : 296 297.
36. Häusermann P, Harr T, Bircher AJ. Baboon syndrome resulting from systemic drugs: is there strife between SDRIFE and allergic contact dermatitis syndrome? Contact Dermat 2004 51 : 297 310.
37. The diagnosis and management of urticaria: a practice parameter part I: acute urticaria/angioedema part II: chronic urticaria/angioedema. Joint Task Force on Practice Parameters. Ann Allergy Asthma Immunol 2000 85 : 521 544.